Wakefield Asset Management Lllp Merck & Co., Inc. Transaction History

Wakefield Asset Management Lllp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	SELL	$87.44 - $112.11 $43,807 - $56,167	-501 Reduced 1.62%	30,487 $3.38 Million
Q3 2022 Nov 07, 2022	SELL	$84.53 - $94.96 $31,276 - $35,135	-370 Reduced 1.18%	30,988 $2.67 Million
Q2 2022 Aug 09, 2022	BUY	$83.49 - $94.64 $2.62 Million - $2.97 Million	31,358 New	31,358 $2.86 Million
Q2 2021 Aug 10, 2021	SELL	$70.31 - $77.77 $301,559 - $333,555	-4,289 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$68.86 - $81.11 $35,394 - $41,690	514 Added 13.62%	4,289 $331,000
Q4 2020 Feb 08, 2021	BUY	$71.77 - $79.65 $4,162 - $4,619	58 Added 1.56%	3,775 $309,000
Q3 2020 Oct 23, 2020	BUY	$73.18 - $82.95 $1,902 - $2,156	26 Added 0.7%	3,717 $308,000
Q2 2020 Jul 28, 2020	SELL	$70.42 - $80.13 $57,744 - $65,706	-820 Reduced 18.18%	3,691 $285,000
Q1 2020 May 12, 2020	BUY	$63.36 - $87.82 $70,456 - $97,655	1,112 Added 32.72%	4,511 $347,000
Q4 2019 Jan 27, 2020	BUY	$77.58 - $87.54 $263,694 - $297,548	3,399 New	3,399 $309,000

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Wakefield Asset Management Lllp, based on Form 13F filings with the SEC.

Stay updated on Wakefield Asset Management Lllp with notifications on news.